Rare diseases
Investigational molecules
Locations
Kresimirova 42, 51000 Rijeka, Croatia
Klinički bolnički centar Rijeka (Clinical Hospital Center Rijeka) in Rijeka, Croatia specialises in clinical trials of conditions such as Dementia Alzheimer's type, Psoriatic arthropathy, Type 2 diabetes mellitus, Arteriosclerosis, and other specialisations. This site conducts important research.
The medical center is at the forefront of neurology research, with a particular focus on epilepsy. The institution is dedicated to advancing the understanding and treatment of refractory focal onset epilepsy, a challenging condition that requires innovative therapeutic approaches.
Through its cutting-edge research, the center contributes significantly to the development of new therapies that aim to improve the quality of life for patients with difficult-to-treat epilepsy. The ongoing studies are pivotal in exploring the efficacy and safety of novel treatments, such as BHV-7000, in reducing seizure frequency.
Clinical trials currently enrolling participants at this site.
Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
CroatiaStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
CroatiaStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
CroatiaStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
CroatiaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
CroatiaStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
CroatiaRifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii
CroatiaA study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity
CroatiaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
CroatiaCroatiaStudy of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer's disease
CroatiaStudy of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer's disease patients
CroatiaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
